Record-Breaking Performance
Pennant Group concluded a year of record-breaking performance with Q4 adjusted earnings per share of $0.24 and a full year 2024 adjusted EPS of $0.94, exceeding guidance.
Significant Revenue and EBITDA Growth
Full year consolidated revenue increased by $150.3 million or 27.6% to $695.2 million. Adjusted EBITDA improved by $12.6 million or 30.9% over the prior year.
Successful Acquisitions and Partnerships
Major acquisitions include the $80 million purchase of Signature Healthcare at Home. Partnerships with John Muir Health and Hartford Healthcare are contributing positively.
Home Health and Hospice Segment Growth
Revenue increased by 31.7% to $519.5 million with a 34.1% rise in adjusted EBITDA. Home health admissions hit a new high, increasing by 40.9%.
Senior Living Segment Improvement
Revenue grew by 16.8% to $175.8 million, with full-year adjusted EBITDA rising by 31.9%. Occupancy increased by 30 basis points to 78.8%.
Strong Financial Position
The company maintains a healthy balance sheet with $245.8 million available on its credit line and $24.2 million in cash on hand.